Stay updated with breaking news from Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw strong trading volume on Wednesday . 620,360 shares traded hands during mid-day trading, an increase of 129% from the previous session’s volume of 271,139 shares.The stock last traded at $15.96 and had previously closed at $15.07. Analyst Upgrades and Downgrades A number of […]
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) – Analysts at Wedbush upped their FY2023 earnings per share estimates for shares of Alpine Immune Sciences in a research report issued on Wednesday, November 15th. Wedbush analyst R. Driscoll now forecasts that the biotechnology company will earn ($0.96) per share for the year, up from their […]
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.